Skip to main content
Signal8

EMSTER KURT VON

SEC insider (Form 3/4/5 filer). CIK 0001252524. Director at Iambic Therapeutics, Inc. (IAM) and 1 other issuer. 3 reported Form 4/5 transactions since Sep 2024; latest on Oct 14, 2026. Located in SAN DIEGO, CA.

Companies EMSTER KURT VON has filed insider reports for

  • Iambic Therapeutics, Inc. (IAM): Director
  • Jasper Therapeutics, Inc. (JSPR): Director
EMSTER KURT VON profile photo

EMSTER KURT VON

CIK: 0001252524

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

Iambic Therapeutics, Inc. logo
IAM

Iambic Therapeutics, Inc.

Director
Jasper Therapeutics, Inc. logo
JSPR

Jasper Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Iambic Therapeutics, Inc. logo
    IAM

    Iambic Therapeutics, Inc.

    Oct 14, 2026
    Award

    Stock Option (right to buy)

    Direct
    20.3K shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 31, 2026
    Award

    Stock Option (Right to Buy

    Direct
    7.5K shares-
  • Jasper Therapeutics, Inc. logo
    JSPR

    Jasper Therapeutics, Inc.

    Jul 3, 2025
    Award

    Stock Option (right to buy)

    Direct
    7.5K shares-

1-3 of 3